Business & Industry
Business & Industry
No New Drug Submissions by the FDA With Shutdown in Place
The Food and Drug Administration (FDA), which is already reeling from the layoffs and leadership changes within the Trump Administration, has warned that the government...
BioPharma
Kadans Science Partner secures one of the most significant deals in Glasgow of H1 2025
Chemify scales up operations at Health Innovation Hub
Digital chemistry company Chemify is set to embark on the next phase of its business journey with...
Business & Industry
Technology Transfer Models for Emerging Pharmaceutical Hubs
Technology Transfer Models for Emerging Pharmaceutical Regions
The global pharmaceutical landscape is experiencing a fundamental transformation as technology transfer models for emerging pharmaceutical regions reshape industry...
Business & Industry
U.S. Tariff Relief for EU and Japan on Pharmaceuticals
Donald Trump’s new tariffs when it comes to pharmaceutical imports are not going to apply to countries having negotiated agreements with the U.S. that contain...
Business & Industry
FDA Targets Drugmakers with Letters in a Marketing Crackdown
After the FDA went on to state that it was taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates...
Business & Industry
Trump Order to Go Heavy on D2C Pharmaceutical Ads
US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per...
Business & Industry
Is US Planning Executive Order on Chinese Pharma Companies?
It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.